Study to Evaluate the Safety and Efficacy ofJaktinib Hydrochloride Tablets in Severe Alopecia Areata

NCT04034134 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

111

Enrollment

INDUSTRY

Sponsor class

Conditions

Alopecia Areata

Interventions

DRUG: Jaktinib Hydrochloride Tablets
DRUG: Jaktinib Hydrochloride Tablets
DRUG: Jaktinib Hydrochloride Tablets

Sponsor

Suzhou Zelgen Biopharmaceuticals Co.,Ltd